High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease - Wikidata - wikimedia - TriplyDB

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

http://www.wikidata.org/entity/Q24628838

about

sameAs

Fungal allergy in asthma-state of the art and research needs Targeting UDP-galactopyranose mutases from eukaryotic human pathogens Antifungal susceptibility testing: current role from the clinical laboratory perspective Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.Impact of the lectin chaperone calnexin on the stress response, virulence and proteolytic secretome of the fungal pathogen Aspergillus fumigatus.Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013 Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer.Insights into fungal communities in composts revealed by 454-pyrosequencing: implications for human health and safety.SNaPAfu: a novel single nucleotide polymorphism multiplex assay for aspergillus fumigatus direct detection, identification and genotyping in clinical specimens Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013 Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis High-Level Pan-Azole-Resistant Aspergillosis Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.Microbial yield from physiotherapy assisted sputum production in respiratory outpatients.Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Is azole resistance in Aspergillus fumigatus a problem in Spain?cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.Challenges in microbiological diagnosis of invasive Aspergillus infections.Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.Azole resistance in Aspergillus: global status in Europe and Asia.The impact of azole resistance on aspergillosis guidelines.Multifocal pulmonary aspergillomas: case series and review.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Enhancing molecular approaches for diagnosis of fungal infections.Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?Current challenges in the microbiological diagnosis of invasive aspergillosis.Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.The future of fungal susceptibility testing.Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach.

P2860

Q22001138-084CBDCF-55AA-4A01-8848-ED63983BF6D4 Q26862107-C337523B-1982-4CCB-8D02-CE8535C5BAE9 Q26862478-00CFA0C9-AF61-4D75-821F-241410C47260 Q26999421-703A447B-B2B8-418D-A529-8D42A3140414 Q28082352-F05FC61C-1D91-441B-8707-54C86F659074 Q28481341-6E9D3302-F694-4219-B12E-92F3096A4B96 Q28485433-7B8B305D-FB38-463F-A42B-5CF8E139416B Q30239051-70334503-1944-4EBF-9BBD-B60F0CBB032B Q34098323-603C4C2D-1705-4098-8154-52A9034FDF95 Q34259732-2169BABE-3C75-4894-85F2-24CFFE7F8BDA Q34532546-BBA49974-780A-4ECB-BE45-A207E6C7F436 Q34688953-BB69E24D-732A-4A94-94D7-EFAD52A58CC3 Q34778557-28DAB9D3-4A32-42D2-8EB1-20571F978862 Q35034529-D682A9F1-07F3-407F-8BE0-C5090228BA1B Q35215022-7735E2AA-FBCE-47D5-B1DA-F86C932C86F6 Q35599066-CFDA51CA-513C-455D-8719-036491627EC5 Q35679674-EC8A2E5F-03D3-4311-871E-FA9C7C8DAFF6 Q35757617-E797093C-938B-458D-AA58-4D196D2D892A Q35757766-122E2F86-A10C-4051-816A-74824E5510D3 Q35848799-D51E6A04-F3DD-4B16-845D-6F0343AC8D35 Q35910668-FE8027C7-B7F8-484B-B81D-290D20FFAAFE Q36439193-FF2B0A60-41F7-482F-8851-D6D142BCE460 Q37026702-947DCA8F-BB5F-4F91-AAF8-6462C6D09042 Q37036556-06B883FF-4868-4E8C-A430-73DDD16AEF9B Q37111641-E3F4FD32-8D70-4276-976D-72D78834CBF0 Q37136645-4EA1D0EC-C2C2-4FA4-85E2-E20E8E48FA58 Q37287794-E27F7F09-26EA-4570-9F21-2A6DFEF25A42 Q37603643-9350092D-E434-4C0F-B7C0-EE68171849B2 Q37659157-2CDCDC4A-0D16-4CEF-9F2E-B036E02EE18C Q37987893-D0382B9A-66CB-4D61-A92D-1B62C6F9ECBD Q38066613-C56607D5-94E7-4AB2-A385-ADE6D443E26A Q38066615-06C62B1C-2647-4FF1-8111-F575F40766EF Q38066618-A2DFA52A-0112-46E9-AA5B-1480BB2C62D3 Q38103889-D4A3B141-536C-46D8-8189-3D972DAC4C71 Q38165198-8CA111BA-B4C8-41B8-95F3-FF027A3B357C Q38206867-B0F22963-E4D3-46FB-A2B2-72D40DF92474 Q38221673-126DB44B-1CA9-44E9-AE65-BA2422A6776B Q38222570-21D1DA12-F4ED-472E-86A8-7B27C5282709 Q38258833-733BA947-C132-4952-8739-9EB51BE68932 Q38269149-0C7B3E6E-B524-4527-B21C-C1C56972135E

P2860

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

http://www.wikidata.org/entity/Q24628838

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

High-frequency triazole resist ...... ts with chronic fungal disease

@ast

High-frequency triazole resist ...... ts with chronic fungal disease

@en

High-frequency triazole resist ...... ts with chronic fungal disease

@nl

type

label

High-frequency triazole resist ...... ts with chronic fungal disease

@ast

High-frequency triazole resist ...... ts with chronic fungal disease

@en

High-frequency triazole resist ...... ts with chronic fungal disease

@nl

prefLabel

High-frequency triazole resist ...... ts with chronic fungal disease

@ast

High-frequency triazole resist ...... ts with chronic fungal disease

@en

High-frequency triazole resist ...... ts with chronic fungal disease

@nl

P1433

Q24628838-9E135F02-925D-43F1-8E17-5019F89197B3

P1476

Q24628838-7A801B04-67C9-4F8B-ADB9-79DABC86E6A7

P2093

Q24628838-09CF43CA-6279-47A6-9ACC-4205F4214D39

Q24628838-3CB4DB10-AE81-4ECE-BCEC-A9A10179FB94

Q24628838-7888CBD1-2FC8-46FF-9DE9-5ABA59CA1278

Q24628838-8213D378-BF72-4AFC-8756-CA2C4527A26D

Q24628838-84C20A02-A79B-4599-8984-8F91C88020F6

Q24628838-907E0FE8-6A24-4817-9C8B-3F716449E1EA

Q24628838-BD3092DB-7A00-487D-9E46-8B576A1AE35F

Q24628838-BF31253F-1150-41BA-8C09-692D96F63033

P2860

Q24628838-01761C95-CB0D-4E55-BD9B-FC21A5480A91

Q24628838-03A64863-7AD9-4956-94B7-B29B008BAF10

Q24628838-1A3E36CE-D2E1-4FA3-8EF9-931ED7D5CB24

Q24628838-1AEF2EC5-E430-4D2C-A2B4-B59735B72E4C

Q24628838-1C50528C-9E62-49FD-8600-4E58327EDBC8

Q24628838-239BC7D3-9765-462E-97E2-B7E2F183B23E

Q24628838-2BEF38B9-926E-44A1-B4F2-FFBA48624756

Q24628838-32325147-F7E3-495A-B012-1F278BB1326F

Q24628838-3E57FC49-8BA3-49CE-A33F-A56A348CA9CD

Q24628838-3E8685FD-E0A9-4B32-9A41-F6699B7667CE

P304

Q24628838-18E0FDC2-934D-46F5-A07D-9C7761D4FD20

P31

Q24628838-ED587491-FECC-491A-B19A-EBDBB88D6D20

P3181

Q24628838-95C6937A-3DE5-45EF-AF0C-0032CBE2F611

P356

Q24628838-DA0A020C-1AAD-4133-B726-EAFEC7658E69

P407

Q24628838-9C41F45C-2D79-4E7B-BAF9-6385640171A1

P433

Q24628838-E1822C04-9FDF-4FDA-A969-BBC3CA754810

P478

Q24628838-03DEF103-8A12-40E1-B605-362895F109F9

P50

Q24628838-33EBCD26-BDA5-46A0-9876-68C1211059DC

Q24628838-9E6DCEC3-EB12-4B91-811A-452C87ABD513

Q24628838-9FB36C78-6E93-4B2F-BD22-DD7DA0130525

P577

Q24628838-B3F33554-9EAC-434E-8E74-B9FA03109226

P5875

Q24628838-14A35888-CF94-4D5A-868C-42564875AAD9

P698

Q24628838-854C321E-12D2-409B-85A5-0917CC6B4453

P921

Q24628838-23BCD2EC-07AB-487F-8644-AB515080CA3F

Q24628838-32BC437A-FC9A-4D65-B28C-B0349E3BC9A1

Q24628838-8D7E8B04-F025-47D3-9B2D-018D80EFED04

P932

Q24628838-FA4234DC-241F-49D3-B70D-8A72ED4A5CEB

P3181

P356

P1433

Clinical Infectious Diseases

P1476

High-frequency triazole resist ...... ts with chronic fungal disease

@en

P2093

Ahmed Bueid

http://www.w3.org/2001/XMLSchema#string

Caroline B Moore

http://www.w3.org/2001/XMLSchema#string

David S Perlin

http://www.w3.org/2001/XMLSchema#string

Marcin G Fraczek

http://www.w3.org/2001/XMLSchema#string

Marie Kirwan

http://www.w3.org/2001/XMLSchema#string

Paul Bowyer

http://www.w3.org/2001/XMLSchema#string

Robin Gore

http://www.w3.org/2001/XMLSchema#string

Steven Park

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus

Surveillance of fungal allergic sensitization using the fluorescent halogen immunoassay

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

Surface hydrophobin prevents immune recognition of airborne fungal spores

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.

Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.

Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.

P304

1123-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4227838

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/CID/CIR179

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

David W. Denning

Jaclyn A. Smith

Cornelia Lass-Flörl

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51019837

http://www.w3.org/2001/XMLSchema#string

P698

21467016

http://www.w3.org/2001/XMLSchema#string

P921

Aspergillus fumigatus

infectious disease

14-alpha sterol demethylase

P932

3106268

http://www.w3.org/2001/XMLSchema#string